Markus Herrmann, PhD

Department of Clinical Pathology, Central Hospital of Bolzano, BZ, Italy

Prof. Markus Herrmann trained as a clinical pathologist at the University Hospital of Saarland in Germany. He led an internationally renowned research group recognized in the field of hyperhomocysteinemia, B-vitamin deficiency and bone disease.

Between 2003 and 2007, he established an active research group that investigated the adverse effects of hyperhomocysteinemia and B-vitamin deficiency on bone. In 2007, Prof. Herrmann was awarded a post-doctoral fellowship by the Academy of Natural Scientists Leopoldina (Germany) and moved to Australia. He joined the ANZAC Research Institute at the University of Sydney, where he was working on cellular mechanisms of glucocorticoid induced osteoporosis. Subsequently, Prof. Herrmann worked as a Chemical Pathologist at Laverty Pathology and the Biochemistry Department of the Royal Prince Alfred Hospital in Sydney. In 2010, he was appointed as Clinical Associate Professor at the University of Sydney. Two years later, Prof. Herrmann was appointed as the director of the Department of Clinical Pathology at Bolzano hospital in Italy. Under his leadership the laboratory developed into an internationally renowned center with a special expertise in LC-MS/MS. In 2017, Prof. Herrmann received a full professorship at the Medical University of Graz and was appointed as the head of the Clinical Institute of Medical and Chemical Laboratory Diagnostics.

His main expertise is in metabolic bone diseases, telomere biology, vitamin D and B deficiency related diseases. Prof. Herrmann’s expertise is documented by over 90 peer-reviewed-publications in scientific journals and book chapters. He is also a regular speaker at international conferences.